Beacon Biosignals, a leading neurotechnology company powering AI-driven neurodiagnostics and precision medicines for the brain, today announced a multi-year expansion of its strategic collaboration ...
Nina Shand couldn’t stay awake. She had taken afternoon naps since she was a teenager to accommodate her “work hard, play hard” attitude, but when she was in her mid-20s the sleepiness became more ...
Imagine not being able to control when and where you fall asleep. One moment, you're sitting at your desk working or talking to someone and the next, you wake up with your head on the desk. You've ...
(CNN) — Matthew Horsnell began falling asleep for no reason when he was in sixth grade. “I would go to bed at 8:30 at night, yet every morning I would wake up and struggle to get out of bed,” said ...
Nina Shand couldn’t stay awake. She had taken afternoon naps since she was a teenager to accommodate her “work hard, play hard” attitude, but when she was in her mid-20s the sleepiness became more ...
The age of onset of narcolepsy ranges from childhood to the fourth decade of life, with onset after 50s being rare. Onset at an advanced age is one of the factors involved in the delay in diagnosis.
They also had sleep disorders, including insomnia (OR 1.84, 95% CI 1.57-2.17, P<0.001), obstructive sleep apnea (OR 3.27, 95% CI 2.83-3.79, P<0.001), or restless leg syndrome (OR 3.94, 95% CI ...
Alkermes already has positive results for alixorexton in NT1 from the phase 2 Vibrance-1, while Takeda is developing another ...
Alkermes' alixorexton met key goals in a phase 2 study for narcolepsy type 2, showing significant improvements in wakefulness and sleepiness scores.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback